The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Leukotriene-Receptor Expression on Nasal Mucosal Inflammatory Cells in Aspirin-Sensitive Rhinosinusitis
Open accessAbstract
BACKGROUND: Patients with asthma who have aspirin sensitivity have greater cysteinyl leukotriene production and greater airway hyperresponsiveness to the effects of inhaled cysteinyl leukotrienes than their aspirin-tolerant counterparts. We hypothesized that the latter effect reflects elevated expression of the cysteinyl leukotriene receptor CysLT1 on inflammatory cells in the target organ and that its expression is down-regulated by aspirin desensitization. METHODS: We obtained nasal-biopsy specimens from 22 aspirin-sensitive and 12 non-aspirin-sensitive patients with chronic rhinosinusitis and nasal polyps. Additional specimens were then obtained from subgroups of the aspirin-sensitive patients after intranasal application of lysine aspirin or placebo for two weeks (five and four patients, respectively) or for six months (five and four patients, respectively). The numbers of leukocytes expressing the CysLT1 and leukotriene B4 (LTB4) receptors per unit area of sections of the nasal submucosa were determined by immunohistochemistry. RESULTS: The absolute number of cells expressing the CysLT1 receptor was significantly higher in the aspirin-sensitive patients than in the non-aspirin-sensitive patients (median, 542 cells per square millimeter [range, 148 to 1390] vs. 116 cells per square millimeter [range, 40 to 259]; P<0.001). The percentage of CD45+ leukocytes expressing the CysLT1 receptor was also higher in the aspirin-sensitive subjects (25 percent of CD45+ leukocytes [range, 4 to 50] vs. 5 percent of CD45+ leukocytes [range, 2 to 11]; P<0.001); the percentage of CD45+ leukocytes expressing the LTB4 receptor did not differ significantly between these two groups. Desensitization was associated with a decrease in the numbers of inflammatory cells expressing CysLT1. CONCLUSIONS: The elevated numbers of nasal inflammatory leukocytes expressing the CysLT1 receptor in aspirin-sensitive patients with chronic rhinosinusitis as compared with their non-aspirin-sensitive counterparts and the down-regulation of receptor expression after desensitization to aspirin are probably fundamental in the pathogenesis of aspirin sensitivity and in the mechanism of aspirin desensitization.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Characterization of the human cysteinyl leukotriene CysLT1 receptor
Lynch, K. R., O'Neill, G. P., Liu, Q., Im, D.-S., Sawyer, N., Metters, K. M., Coulombe, N., Abramovitz, M., Figueroa, D. J., Zeng, Z., et al. (1999) · Nature · doi:10.1038/21658 · Cited by 965
Intolerance to Aspirin: Clinical Studies and Consideration of its Pathogenesis
SAMTER, M., & BEERS, R. F. (1968) · Annals of Internal Medicine · doi:10.7326/0003-4819-68-5-975 · Cited by 839
Treatment of Asthma with Drugs Modifying the Leukotriene Pathway
Drazen, J. M., Israel, E., & O'Byrne, P. M. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901213400306 · Cited by 820
Characterization of the Human Cysteinyl Leukotriene 2 Receptor
Heise, C. E., O'Dowd, B. F., Figueroa, D. J., Sawyer, N., Nguyen, T., Im, D.-S., Stocco, R., Bellefeuille, J. N., Abramovitz, M., Cheng, R., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003490200 · Cited by 658
Cowburn, A. S., Sladek, K., Soja, J., Adamek, L., Nizankowska, E., Szczeklik, A., Lam, B. K., Penrose, J. F., Austen, F. K., Holgate, S. T., et al. (1998) · Journal of Clinical Investigation · doi:10.1172/jci620 · Cited by 550
Leukotriene E4 and granulocytic infiltration into asthmatic airways
Laitinen, L. A., Haahtela, T., Vilkka, V, Lee, T. H., & Spur, B. W. (1993) · The Lancet · doi:10.1016/0140-6736(93)91073-u · Cited by 526
Self-citationChristie, P. E., Tagari, P., Ford-Hutchinson, A. W., Charlesson, S., Chee, P., Arm, J. P., & Lee, T. H. (1991) · American Review of Respiratory Disease · doi:10.1164/ajrccm/143.5_pt_1.1025 · Cited by 449
Self-citationKumlin, M., Dahlén, B., Björck, T., Zetterström, O., Granström, E., & Dahlén, S.-E. (1992) · American Review of Respiratory Disease · doi:10.1164/ajrccm/146.1.96 · Cited by 289
Panettieri, R. A., Tan, E. M. L., Ciocca, V., Luttmann, M. A., Leonard, T. B., & Hay, D. W. P. (1998) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.19.3.2999 · Cited by 271
FIGUEROA, D. J., BREYER, R. M., DEFOE, S. K., KARGMAN, S., DAUGHERTY, B. L., WALDBURGER, K., LIU, Q., CLEMENTS, M., ZENG, Z., O'NEILL, G. P., et al. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.1.2003101 · Cited by 262
Cited by
The diagnosis and management of rhinitis: An updated practice parameter
WALLACE, D., DYKEWICZ, M., BERNSTEIN, D., BLESSINGMOORE, J., COX, L., KHAN, D., LANG, D., NICKLAS, R., OPPENHEIMER, J., & PORTNOY, J. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.06.003 · Cited by 1,096
“The numbers of nasal mucosal leukocytes expressing cysLT receptors (cysLT1), which are increased in nasal mucosa of patients with AERD, decrease after aspirin desensitization.(157)”
BackgroundAsthma: defining of the persistent adult phenotypes
Wenzel, S. E. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69290-8 · Cited by 1,043
Peters-Golden, M., & Henderson, W. R. (2007) · New England Journal of Medicine · doi:10.1056/nejmra071371 · Cited by 1,013
Drug Allergy: An Updated Practice Parameter
(2010) · Annals of Allergy, Asthma & Immunology · doi:10.1016/j.anai.2010.08.002 · Cited by 957
Risk factors of readmission to hospital for a COPD exacerbation: a prospective study
Garcia-Aymerich, J. (2003) · Thorax · doi:10.1136/thorax.58.2.100 · Cited by 731
International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis
Wise, S. K., Lin, S. Y., Toskala, E., Orlandi, R. R., Akdis, C. A., Alt, J. A., Azar, A., Baroody, F. M., Bachert, C., Canonica, G. W., et al. (2018) · International Forum of Allergy & Rhinology · doi:10.1002/alr.22073 · Cited by 557
International consensus statement on allergy and rhinology: Allergic rhinitis – 2023
Wise, S. K., Damask, C., Roland, L. T., Ebert, C., Levy, J. M., Lin, S., Luong, A., Rodriguez, K., Sedaghat, A. R., Toskala, E., et al. (2023) · International Forum of Allergy & Rhinology · doi:10.1002/alr.23090 · Cited by 507
Aspirin-induced asthma: Advances in pathogenesis, diagnosis, and management
Szczeklik, A., & Stevenson, D. D. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2003.1487 · Cited by 491
Diagnosis and management of NSAID‐Exacerbated Respiratory Disease (N‐ERD)—a EAACI position paper
Kowalski, M. L., Agache, I., Bavbek, S., Bakirtas, A., Blanca, M., Bochenek, G., Bonini, M., Heffler, E., Klimek, L., Laidlaw, T. M., et al. (2019) · Allergy · doi:10.1111/all.13599 · Cited by 360
Self-citationKanaoka, Y., & Boyce, J. A. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.3.1503 · Cited by 351
Rhinosinusitis: Developing guidance for clinical trials
Meltzer, E. O., Hamilos, D. L., Hadley, J. A., Lanza, D. C., Marple, B. F., Nicklas, R. A., Adinoff, A. D., Bachert, C., Borish, L., Chinchilli, V. M., et al. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.09.005 · Cited by 351
Old and new generation lipid mediators in acute inflammation and resolution
Stables, M. J., & Gilroy, D. W. (2011) · Progress in Lipid Research · doi:10.1016/j.plipres.2010.07.005 · Cited by 334
Rhinosinusitis: Developing guidance for clinical trials
Meltzer, E. O., Hamilos, D. L., Hadley, J. A., Lanza, D. C., Marple, B. F., Nicklas, R. A., Adinoff, A. D., Bachert, C., Borish, L., Chinchilli, V. M., et al. (2006) · Otolaryngology–Head and Neck Surgery · doi:10.1016/j.otohns.2006.09.014 · Cited by 327
Clinical and pathologic perspectives on aspirin sensitivity and asthma
Stevenson, D. D., & Szczeklik, A. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.07.024 · Cited by 324
Bel, E. H. (2004) · Current Opinion in Pulmonary Medicine · doi:10.1097/00063198-200401000-00008 · Cited by 293
Aspirin-Exacerbated Respiratory Disease
White, A. A., & Stevenson, D. D. (2018) · New England Journal of Medicine · doi:10.1056/nejmra1712125 · Cited by 258
Ahn, J.-C., Kim, J.-W., Lee, C. H., & Rhee, C.-S. (2016) · JAMA Otolaryngology–Head & Neck Surgery · doi:10.1001/jamaoto.2015.3142 · Cited by 146
Krouse, J. H., Brown, R. W., Fineman, S. M., Han, J. K., Heller, A. J., Joe, S., Krouse, H. J., Pillsbury, H. C., Ryan, M. W., & Veling, M. C. (2007) · Otolaryngology–Head and Neck Surgery · doi:10.1016/j.otohns.2007.02.019 · Cited by 132
Systemic effects of local allergic disease
Togias, A. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2003.09.051 · Cited by 102
Lipid mediators and allergic diseases
Fanning, L. B., & Boyce, J. A. (2013) · Annals of Allergy, Asthma & Immunology · doi:10.1016/j.anai.2013.06.031 · Cited by 70
Awad, O. G., Fasano, M. B., Lee, J. H., & Graham, S. M. (2008) · American Journal of Rhinology · doi:10.2500/ajr.2008.22.3148 · Cited by 55
Metadata
- Authors
- Sousa, A. R., Parikh, A., Scadding, G., Corrigan, C. J., & Lee, T. H.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2002-11-07
- Volume
- 347
- Issue
- 19
- Pages
- 1493-1499
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2004034703
- Cited by
- 373
- References
- 23
- FWCI
- 24.45
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.